Company overview
Zhejiang Guobang Pharmaceutical Co., Ltd.
USCC
913306007258898636
Id2
330600400010566
English Name
Zhejiang Guobang Pharmaceutical Co., Ltd.
Former names
浙江国邦兽药有限公司, 浙江国邦应用化工有限公司
Chinese Name
浙江国邦药业有限公司
Entity type
Limited Liability Company (Sole Legal-Person Ownership, Non-Natural Person)
Authorized capital
¥13,880
gbhr@gbharm.com
Phone
+8657582738278
Representative
姚礼高 (Yao Li Gao)
Establishment date
6 August 2004
Country
China
Primary goods traded
- 33.9% — Antibiotics (294150)
- 33.0% — Antibiotics (294190)
- 27.2% — Heterocyclic compounds (293359)
- 5.6% — Acids (291830)
- 0.3% — Heterocyclic compounds (293369)
Main Trading Partners
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Tigaka Distrindo Perkasa | buyer | $7,758,853 | 25.08% |
| PT Megasetia Agung Kimia | buyer | $1,759,455 | 5.69% |
| PT Kimia Farma | buyer | $1,495,275 | 4.83% |
| PT Dilimas Mandiri | buyer | $726,152 | 2.35% |
| Wockhardt Limited | buyer | $489,500 | 1.58% |
| PT Dexa Medica | buyer | $474,456 | 1.53% |
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Trade Data
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 30 April 2022 | IN | 29415000 | Azithromycin Usp /Ip (Form 10 No: Il/Bd-011759-Bd-709 Dt: 15/03/2022) | Cipla Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $1,344,000.00 | |
| 19 July 2022 | IN | 29415000 | Azithromycin Usp /Ip (Form 10 No: Il/Bd-011280-Bd-709 Dt: 28/10/2021) | Cipla Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $892,500.00 | |
| 29 November 2022 | NG | 2941900000 | Ciprofloxacin Hcl Usp43 | Sagar Overseas Limited | NG | Zhejiang Guobang Pharmaceutical Company Limited | $764,777.55 | |
| 4 April 2022 | IN | 29415000 | Azithromycin Usp /Ip (Form 10 No: Il/Bd-005870-Bd-709 Dt: 08/04/2020) | Cipla Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $640,833.33 | |
| 21 April 2022 | IN | 29415000 | Azithromycin Amine | Kopran Research Laboratories Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $624,493.84 | |
| 9 May 2022 | IN | 29415000 | Azithromycin Amine | Kopran Research Laboratories Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $612,000.00 | |
| 29 March 2022 | IN | 29415000 | Azithromycin Usp /Ip (Form 10 No: Il/Bd-011280-Bd-709 Dt: 28/10/2021) | Cipla Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $580,500.00 | |
| 26 July 2022 | IN | 29415000 | Azithromycin Usp /Ip (Form 10 No: Il/Bd-011280 Bd-709 Dt: 28/10/21) | Cipla Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $452,200.00 | |
| 30 September 2022 | IN | 29415000 | Azithromycin Usp /Ip (Form 10 No: Il/Bd-011280-Bd-709 Dt: 28/10/2021) | Cipla Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $446,250.00 | |
| 28 November 2018 | IN | 29419090 | Azithromycin Amine | Wockhardt Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $430,500.00 |
0 of 20 row(s) selected.